Vanda Pharmaceuticals Inc. (LON:0LKB)

London flag London · Delayed Price · Currency is GBP · Price in USD
7.61
+0.09 (1.22%)
At close: Jan 21, 2026
74.57%
Market Cap354.75M
Revenue (ttm)157.77M
Net Income (ttm)-62.64M
Shares Outn/a
EPS (ttm)-1.07
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,982
Average Volume45,892
Open7.80
Previous Close7.52
Day's Range7.61 - 7.86
52-Week Range3.83 - 9.60
Beta0.61
RSI56.83
Earnings DateFeb 12, 2026

About Vanda Pharmaceuticals

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company’s marketed products include HETLIOZ to treat non-24-hour sleep-wake disorders; Fanapt (iloperidone) for the treatment of bipolar I disorder and Parkinson’s disease psychosis, as well as a long acting injectable (LAI) formulation to treat schizophrenia; and Ponvory for the treatment of psoriasis and ulcerative colitis. Its pipeline products include HETLIOZ (tasimelteon) ... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2002
Employees 368
Stock Exchange London Stock Exchange
Ticker Symbol 0LKB
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements